2016 CHAUSSON FLASH2.2L Diesel

The 2016 Chausson Flash presents a clean roadworthiness profile with a stable maintenance trend, evidenced by the most recent DVSA test on 8 April 2026, just three months prior to the present date, returning a pass at 23,917 miles with no defects recorded. Earlier examinations reinforce this pattern. The tester issued no advisories across five consecutive annual tests from April 2022 to April 2026. Such consistency indicates the vehicle has satisfied statutory standards without recurring mechanical or structural concerns. Mileage accumulation sits well below typical expectations for a ten-year-old motorhome, averaging roughly 2,392 miles per year. The record shows 12,184 miles at the 13 April 2022 test, rising to 14,952 miles on 5 April 2023, 19,399 miles on 11 April 2024, 22,453 miles on 3 April 2025, and 23,917 miles on 8 April 2026. No abrupt jumps or dormant gaps appear; the annual increments of two to five thousand miles suggest gentle touring use. The sparse but unbroken history offers little scope for wear-driven faults, though low utilisation can mask deterioration from standing. A buyer should still commission a physical inspection of components prone to age rather than mileage degradation. The MOT sheets never flagged corrosion, yet structural integrity around chassis rails and floor pans warrants close scrutiny for rust bloom given the 2016 build. Suspension bushes and coil springs may have hardened or cracked through inactivity despite showing no play at test. Brake discs and calipers demand checks for binding or surface pitting after prolonged static periods. Tyres and wiper blades fall into consumable categories but perished rubber from low rotation remains a risk not always caught by tread depth measurements. The absence of recorded advisories does not exempt the drivetrain from verifying fluid conditions and exhaust emissions integrity on a cold start. Prior owners clearly adhered to basic statutory testing; however, low mileage alone does not confirm thorough preventative care beyond the test bay.